Patient is given 0.5IU of oxytocin intravenously over 1 minute, immediately upon delivery of the fetal head.

Patient is given 1IU of oxytocin intravenously over 1 minute, immediately upon delivery of the fetal head.

Patient is given 2IU of oxytocin intravenously over 1 minute, immediately upon delivery of the fetal head.

Patient is given 3IU of oxytocin intravenously over 1 minute, immediately upon delivery of the fetal head.

Patient is given 4IU of oxytocin intravenously over 1 minute, immediately upon delivery of the fetal head.

Patient is given 5IU of oxytocin intravenously over 1 minute, immediately upon delivery of the fetal head.

Postpartum Hemorrhage

Twin

Oxytocin administered intravenously, over 1 minute following delivery of the fetal head

Oxytocin

Mount Sinai Hospital

Oxytocin at Elective Cesarean Deliveries: A Dose-finding Study in Women With Twin Pregnancy

Uterine tone, defined as satisfactory or unsatisfactory by the obstetrician at 2 minutes after completion of the oxytocin injection (3 minutes post delivery).

The obstetricians will be asked if there was any need for uterine massage beyond the initial 3 minute evaluation period following delivery.

A request made by the obstetrician performing the cesarean delivery for additional uterotonic medication, due to bleeding or poor uterine tone.

Blood loss will be calculated through the difference in hematocrit values assessed prior to and at the end of 48 hours after the cesarean delivery, according to the following formula:
Calculated blood loss = EBV ((Pre-op Htc-Post-op Htc)/pre-op Htc). EBV (estimated blood volume) in ml: patient's weight in kg x 85

The total volume (ml) of fluid administered from entering the operating room to skin closure.

Systolic blood pressure < 80% of baseline, from drug administration until end of surgery

Heart rate > 130% of baseline, from drug administration until end of surgery

Heart rate < 70% of baseline or a heart rate < 50bpm, from drug administration until end of surgery

Presence of ventricular tachycardia as recorded by ECG, from drug administration until end of surgery

Presence of atrial fibrillation as recorded by ECG, from drug administration until end of surgery

Presence of atrial flutter as recorded by ECG, from drug administration until end of surgery

The presence of nausea and number of episodes, from drug administration until end of surgery, as reported by the patient

The presence of vomiting and number of episodes, from drug administration until end of surgery

Any presence of chest pain, from drug administration until end of surgery, as reported by the patient

Any presence of shortness of breath, from drug administration until end of surgery, as reported by the patient

Any presence of headache, from drug administration until end of surgery, as reported by the patient

Any presence of flushing, from drug administration until end of surgery

Samuel Lunenfeld Research Institute, Mount Sinai Hospital

Multiple Gestation

Cesarean Delivery

Anesthesia

Anesthesiology department, Siriraj hospital, Mahidol University

Incidence of Complications Associated With Anesthesia in Multiple Gestation Undergoing Cesarean Delivery

Incidence of Complications Associated With Anesthesia in Multiple Gestation Undergoing Cesarean Delivery: A Retrospective Review

Patchareya Nivatpumin

Assistant professor

Mahidol University

Recruiting only pregnant women prior to child-birth delivery.

misoprostol

Queens Hospital Center

Effect of Adjunctive Misoprostol Treatment on Blood Loss at Vaginal Delivery

Effect of Adjunctive Misoprostol on Blood Loss at Vaginal Delivery

Aleksandr Fuks

Directore, Department OB / GYN , Queens Hospital Center

New York City Health and Hospitals Corporation

a single dose of carbetocin (100 μg in 1 mL ampoule, Pabal) given intravenously after delivery of anterior shoulder

misoprostol (600 μg, 3 tables) sublingually after the delivery of the anterior shoulder of the baby.

Severe Pre-eclampsia, Postpartum Condition or Complication

given after the delivery of the anterior shoulder of the baby.

given after delivery of anterior shoulder

uterine inertia/turvotus

Oxytocin at Elective Cesarean Deliveries: A Dose-finding Study in Women With Twin Pregnancy

Incidence of Complications Associated With Anesthesia in Multiple Gestation Undergoing Cesarean Delivery

Effect of Adjunctive Misoprostol Treatment on Blood Loss at Vaginal Delivery

Prevention of Postpartum Hemorrhage in Patients With Severe Preeclampsia Using Carbetocin Versus Misoprostol

Täydellisin lääketieteellinen tietokanta tieteen tukemana